Prime Therapeutics

Prime Therapeutics is owned by HCSC.

HCSC has 23 subsidiaries including Arkansas Blue Cross and Blue Shield, Availity and Blue Cross & Blue Shield of Illinois.

They are in:

• Insurance83%
• Healthcare8%
• Other8%

Acquisition, funding and merger involving HCSC.

• HCSC has announced the acquisition of Cigna Medicare  (posted on January 4 2024).

View the org chart displaying its 43 main executives

Most searched biographies at Prime Therapeutics

• Mostafa Kamal, President and Chief Executive Officer
• Daniel Conrad, Director
• Chuck Divita, Director

Popular executive movements at Prime Therapeutics

• Ken Bodmer has joined the company as Chief Financial Officer  (posted on December 6 2023).
• Tizgel High has joined the company as Chief Compliance Officer  (posted on September 22 2023).

Popular executive movements at HCSC

• Opella Ernest, who was Executive Vice President, Commercial Markets, is promoted to President, Markets  (posted on October 6 2023).
• James Walsh, who was Senior Vice President and Chief Financial Officer, is promoted to Executive Vice President, Chief Financial Officer  (posted on October 6 2023).

Create your alert
to follow the executive moves at Prime Therapeutics.

HCSC has 1,810 competitors including Siemens Healthineers (Germany), IQVIA (United States (USA)) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• Two Chairs has just announced a $72 Million fundraising (posted on April 18 2024).
• Grow Therapy has just announced a $88 Million fundraising (posted on April 12 2024).
• SSI Strategy and NDA Group have announced they will merge  (posted on April 8 2024)..

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care
• Sima Sistani - Chief Executive Officer and Director at WW International

Learn more about the Healthcare industry >

Press releases by Prime Therapeutics

• Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance - Prime Therapeutics LLC
• Prime Post Newsletter - Prime Therapeutics LLC
• Traditional Drug Pipeline Monthly Update: November 2023 - Prime Therapeutics LLC
• Specialty Drug Pipeline Monthly Update: November 2023 - Prime Therapeutics LLC
• Magellan Medicaid Administration Achieves ISO 9001:2015 Recertification - Prime Therapeutics LLC
• A star-studded event – 2023 Stars and Bid Forum  - Prime Therapeutics LLC
• AMCP Nexus 2023 Live-Blog: Day 1 Collection - Prime Therapeutics LLC
• AMCP Nexus 2023 Preview – A Q&A with Pat Gleason and David Eckwright  - Prime Therapeutics LLC
• Prime Therapeutics and Magellan Rx to present three managed care pharmacy research studies at AMCP Nexus - Prime Therapeutics LLC
• November 2023 decisions expected from the FDA - Prime Therapeutics LLC
• View more press releases Close

Social media about Prime Therapeutics

• Prime Therapeutics on Wikipedia, Google News & Yahoo Finance
• Prime Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Daniel Conrad

Call Prime Therapeutics at +1 612...

View the org chart

Register to receive your alert

Report an error